TARLATAMAB for Small cell carcinoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 5 adverse event reports in the FDA FAERS database where TARLATAMAB was used for Small cell carcinoma.

Most Reported Side Effects for TARLATAMAB

Side Effect	Reports	%	Deaths	Hosp.
Cytokine release syndrome	59	40.7%	11	32
Death	31	21.4%	31	5
Immune effector cell-associated neurotoxicity syndrome	30	20.7%	6	15
Off label use	14	9.7%	2	6
Disease progression	11	7.6%	6	3
Small cell lung cancer	10	6.9%	3	2
Metastases to central nervous system	7	4.8%	2	2
Therapy partial responder	7	4.8%	4	3
Pyrexia	6	4.1%	2	3
Dysgeusia	5	3.5%	1	2
Hypotension	5	3.5%	1	4